CLPT
ClearPoint Neuro Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$10.79
-0.74 ▼ -6.42%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$10.99
+0.20 ▲ +1.85%
| Index | RUT | P/E | - | EPS (ttm) | -0.83 | Insider Own | 13.51% | Shs Outstand | 0.03B | Perf Week | 7.9% |
| Market Cap | 0.32B | Forward P/E | - | EPS next Y | 3.61% | Insider Trans | -1.7% | Shs Float | 0.03B | Perf Month | -19.3% |
| Enterprise Value | 0.32B | PEG | - | EPS next Q | -0.2 | Inst Own | 38.48% | Short Float | 12.92% | Perf Quarter | -17.7% |
| Income | -0.02B | P/S | 9.35 | EPS this Y | -18.57% | Inst Trans | 5.77% | Short Ratio | 4.04 | Perf Half Y | -2.71% |
| Sales | 0.03B | P/B | 19.32 | EPS next 5Y | - | ROA | -46.03% | Short Interest | 3.33M | Perf YTD | -21.13% |
| Book/sh | 0.56 | P/C | 8.4 | EPS past 3/5Y | -0.23% -10.69% | ROE | -103.13% | 52W High | -64.15% ($30.10) | Perf Year | -14.09% |
| Cash/sh | 1.28 | P/FCF | - | Sales past 3/5Y | 24.42% 22.85% | ROIC | -45.13% | 52W Low | 25.03% ($8.63) | Perf 3Y | 38.16% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -19.53% | Gross Margin | 61.31% | Volatility(W/M) | 7.16% 8.46% | Perf 5Y | -46.72% |
| Dividend TTM | - | EV/Sales | 9.28 | Sales Y/Y TTM | 12.83% | Oper. Margin | -66.19% | ATR (14) | 1.11 | Perf 10Y | -18.21% |
| Dividend Ex-Date | - | Quick Ratio | 5.56 | EPS Q/Q | -14.92% | Profit Margin | -67.4% | RSI (14) | 41.65 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.37 | Sales Q/Q | 9.1% | SMA20 | -11.89% ($12.25) | Beta | 1.08 | Target Price | $24 |
| Payout | - | Debt/Eq | 2.25 | Earnings | 3000000 | SMA50 | -19.39% ($13.39) | Rel Volume | 0.73 | Prev Close | $11.53 |
| Employees | 115 | LT Debt/Eq | 2.23 | EPS/Sales Surpr. | -5% -7.7% | SMA200 | -24.93% ($14.37) | Avg Volume(3M) | 0.82M | Price | $10.79 |
| IPO | 2012/5/21 | Option/Short | Yes/Yes | Trades | 6443 | Volume | 605,263 | Change | -6.42% |
뉴스 로딩 중...